• Profile
Close

Relationship between pain reduction and improvement in health-related quality of life in patients with knee pain due to osteoarthritis receiving duloxetine: Exploratory post hoc analysis of a Japanese phase 3 randomized study

Journal of Pain Research Jan 26, 2020

Enomoto H, et al. - In this post hoc analysis of a Japanese phase 3 randomized study, researchers examined how changes in pain severity and changes in health-related quality of life (HRQoL) are correlated in patients treated with duloxetine for knee osteoarthritis (OA). Duloxetine 60 mg/day or placebo was provided for 14 weeks to patients with knee OA and Brief Pain Inventory (BPI) average pain score ≥ 4. Duloxetine (n = 177) vs placebo (n = 176) led to a significantly greater improvement in BPI average pain severity score and significantly greater improvements in 5 of the 8 SF-36 (36-item Short-Form Health Survey; a generic measure of HRQoL) domains (including the Role-Physical, Bodily Pain, and Physical Functioning domains) and all 24 individual Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC; an OA-specific measure of HRQoL) items. Outcomes thereby suggest that in duloxetine-treated patients with knee OA, the pain decrease was correlated with improvements in OA-specific aspects of HRQoL, ie, pain and physical functioning.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay